Sun Pharmaceutical Industries Limited
SUNPHARMA
Rang in Aktien
#525
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Aktienkurs
$19.19
Zuletzt synchronisiert: 2026-10-21
Marktkapitalisierung
$46.04B
Veränderung (1 Tag)
-0.25%
Veränderung (1 Jahr)
-0.09%
Land
IN
Handel Sun Pharmaceutical Industries Limited (SUNPHARMA)
Kategorie
Healthcare
Kursverlauf für Sun Pharmaceutical Industries Limited (SUNPHARMA)
Höchster Schlusskurs: $19.47 am 2026-10-01
Niedrigster Schlusskurs: $0.02 am 1996-01-01
Niedrigster Schlusskurs: $0.02 am 1996-01-01
Kursverlauf der Aktie von Sun Pharmaceutical Industries Limited von 1996 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 0.89% |
| 2025 | -7.91% |
| 2024 | 43.53% |
| 2023 | 22.20% |
| 2022 | 18.11% |
| 2021 | 33.19% |
| 2020 | 27.66% |
| 2019 | 1.58% |
| 2018 | -27.66% |
| 2017 | -14.52% |
| 2016 | -16.96% |
| 2015 | -11.56% |
| 2014 | 40.91% |
| 2013 | 40.72% |
| 2012 | 36.94% |
| 2011 | -4.41% |
| 2010 | 58.19% |
| 2009 | 46.03% |
| 2008 | -24.72% |
| 2007 | 32.88% |
| 2006 | 46.09% |
| 2005 | 25.97% |
| 2004 | 74.23% |
| 2003 | 127.83% |
| 2002 | 1.28% |
| 2001 | 3.29% |
| 2000 | -13.97% |
| 1999 | 1,277.91% |
| 1998 | 21.14% |
| 1997 | 7.46% |
| 1996 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $7.00 | -23.54% |
CN
|
